New

Ulcerative Colitis Treatment Market

2021

Ulcerative Colitis Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Ulcerative Proctitis, Proctosigmoiditis, Left-Sided Colitis, Pancolitis or Universal Colitis, and Fulminant Colitis); Medication (5-Aminosalicylates, Steroids, Purine Analogs, Immunomodulators, and Biologics)

| Report Code: TIPRE00019337 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Ulcerative Colitis Treatment Market 2028 By Type, Medication | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Ulcerative colitis is a chronic idiopathic inflammatory gastrointestinal bowel disease (IBD) that damages the mucous membrane of the colon. It usually happens in individuals between 15 and 30 years of age. Ulcerative colitis along with Crohn's disease is one of two major forms of IBD. Ulcerative colitis typically requires only large intestines, as opposed to Crohn's disease, which can affect any part of the gastrointestinal tract.

MARKET DYNAMICS

Growing incidence of ulcerative colitis affecting millions of people worldwide is fueling the development of the world market for ulcerative colitis. In addition, there is a huge amount of R&D and funding from key players in creating innovative UC drugs and increasing the business development of government and non-governmental organisations in the field of biological science. However, prescription patents and tight regulatory controls on biosimilar approvals restrict the expansion of business. Failure to meet the UC criteria offers attractive growth prospects for the industry.

MARKET SCOPE

The "Ulcerative Colitis Treatment Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Ulcerative Colitis Treatment Market with detailed market segmentation by type, and medication. The Ulcerative Colitis Treatment Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Ulcerative Colitis Treatment Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Ulcerative Colitis Treatment Market is segmented on the basis of type, medication. Based on type, the market is segmented as Ulcerative Proctitis, Proctosigmoiditis, Left-Sided Colitis, Pancolitis or Universal Colitis, and Fulminant Colitis. Based on medication, the market is segmented as 5-Aminosalicylates, Steroids, Purine Analogs, Immunomodulators, and Biologics.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Ulcerative Colitis Treatment Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Ulcerative Colitis Treatment Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Ulcerative Colitis Treatment Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Ulcerative Colitis Treatment Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Ulcerative Colitis Treatment Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Ulcerative Colitis Treatment Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Ulcerative Colitis Treatment Market in the global market. Below mentioned is the list of few companies engaged in the Ulcerative Colitis Treatment Market.

The report also includes the profiles of key players in Ulcerative Colitis Treatment Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Pfizer
  •   Novartis
  •   Roche
  •   Johnson and Johnson
  •   Bayer
  •   AbbVie
  •   Sanofi
  •   GSK
  •   AstraZeneca
  •   MSD

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Ulcerative Colitis Treatment - By Type
1.3.2 Ulcerative Colitis Treatment - By Medication
1.3.3 Ulcerative Colitis Treatment - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ULCERATIVE COLITIS TREATMENT LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ULCERATIVE COLITIS TREATMENT - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ULCERATIVE COLITIS TREATMENT - GLOBAL MARKET ANALYSIS
6.1. ULCERATIVE COLITIS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. ULCERATIVE COLITIS TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ULCERATIVE COLITIS TREATMENT - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ULCERATIVE PROCTITIS
7.3.1. Overview
7.3.2. Ulcerative Proctitis Market Forecast and Analysis
7.4. PROCTOSIGMOIDITIS
7.4.1. Overview
7.4.2. Proctosigmoiditis Market Forecast and Analysis
7.5. LEFT-SIDED COLITIS
7.5.1. Overview
7.5.2. Left-Sided Colitis Market Forecast and Analysis
7.6. PANCOLITIS OR UNIVERSAL COLITIS
7.6.1. Overview
7.6.2. Pancolitis or Universal Colitis Market Forecast and Analysis
7.7. AND FULMINANT COLITIS
7.7.1. Overview
7.7.2. and Fulminant Colitis Market Forecast and Analysis
8. ULCERATIVE COLITIS TREATMENT - REVENUE AND FORECASTS TO 2028 - MEDICATION
8.1. OVERVIEW
8.2. MEDICATION MARKET FORECASTS AND ANALYSIS
8.3. 5-AMINOSALICYLATES
8.3.1. Overview
8.3.2. 5-Aminosalicylates Market Forecast and Analysis
8.4. STEROIDS
8.4.1. Overview
8.4.2. Steroids Market Forecast and Analysis
8.5. PURINE ANALOGS
8.5.1. Overview
8.5.2. Purine Analogs Market Forecast and Analysis
8.6. IMMUNOMODULATORS
8.6.1. Overview
8.6.2. Immunomodulators Market Forecast and Analysis
8.7. AND BIOLOGICS
8.7.1. Overview
8.7.2. and Biologics Market Forecast and Analysis
9. ULCERATIVE COLITIS TREATMENT REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Ulcerative Colitis Treatment Overview
9.1.2 North America Ulcerative Colitis Treatment Forecasts and Analysis
9.1.3 North America Ulcerative Colitis Treatment Forecasts and Analysis - By Type
9.1.4 North America Ulcerative Colitis Treatment Forecasts and Analysis - By Medication
9.1.5 North America Ulcerative Colitis Treatment Forecasts and Analysis - By Countries
9.1.5.1 United States Ulcerative Colitis Treatment
9.1.5.1.1 United States Ulcerative Colitis Treatment by Type
9.1.5.1.2 United States Ulcerative Colitis Treatment by Medication
9.1.5.2 Canada Ulcerative Colitis Treatment
9.1.5.2.1 Canada Ulcerative Colitis Treatment by Type
9.1.5.2.2 Canada Ulcerative Colitis Treatment by Medication
9.1.5.3 Mexico Ulcerative Colitis Treatment
9.1.5.3.1 Mexico Ulcerative Colitis Treatment by Type
9.1.5.3.2 Mexico Ulcerative Colitis Treatment by Medication
9.2. EUROPE
9.2.1 Europe Ulcerative Colitis Treatment Overview
9.2.2 Europe Ulcerative Colitis Treatment Forecasts and Analysis
9.2.3 Europe Ulcerative Colitis Treatment Forecasts and Analysis - By Type
9.2.4 Europe Ulcerative Colitis Treatment Forecasts and Analysis - By Medication
9.2.5 Europe Ulcerative Colitis Treatment Forecasts and Analysis - By Countries
9.2.5.1 Germany Ulcerative Colitis Treatment
9.2.5.1.1 Germany Ulcerative Colitis Treatment by Type
9.2.5.1.2 Germany Ulcerative Colitis Treatment by Medication
9.2.5.2 France Ulcerative Colitis Treatment
9.2.5.2.1 France Ulcerative Colitis Treatment by Type
9.2.5.2.2 France Ulcerative Colitis Treatment by Medication
9.2.5.3 Italy Ulcerative Colitis Treatment
9.2.5.3.1 Italy Ulcerative Colitis Treatment by Type
9.2.5.3.2 Italy Ulcerative Colitis Treatment by Medication
9.2.5.4 Spain Ulcerative Colitis Treatment
9.2.5.4.1 Spain Ulcerative Colitis Treatment by Type
9.2.5.4.2 Spain Ulcerative Colitis Treatment by Medication
9.2.5.5 United Kingdom Ulcerative Colitis Treatment
9.2.5.5.1 United Kingdom Ulcerative Colitis Treatment by Type
9.2.5.5.2 United Kingdom Ulcerative Colitis Treatment by Medication
9.2.5.6 Rest of Europe Ulcerative Colitis Treatment
9.2.5.6.1 Rest of Europe Ulcerative Colitis Treatment by Type
9.2.5.6.2 Rest of Europe Ulcerative Colitis Treatment by Medication
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Ulcerative Colitis Treatment Overview
9.3.2 Asia-Pacific Ulcerative Colitis Treatment Forecasts and Analysis
9.3.3 Asia-Pacific Ulcerative Colitis Treatment Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Ulcerative Colitis Treatment Forecasts and Analysis - By Medication
9.3.5 Asia-Pacific Ulcerative Colitis Treatment Forecasts and Analysis - By Countries
9.3.5.1 Australia Ulcerative Colitis Treatment
9.3.5.1.1 Australia Ulcerative Colitis Treatment by Type
9.3.5.1.2 Australia Ulcerative Colitis Treatment by Medication
9.3.5.2 China Ulcerative Colitis Treatment
9.3.5.2.1 China Ulcerative Colitis Treatment by Type
9.3.5.2.2 China Ulcerative Colitis Treatment by Medication
9.3.5.3 India Ulcerative Colitis Treatment
9.3.5.3.1 India Ulcerative Colitis Treatment by Type
9.3.5.3.2 India Ulcerative Colitis Treatment by Medication
9.3.5.4 Japan Ulcerative Colitis Treatment
9.3.5.4.1 Japan Ulcerative Colitis Treatment by Type
9.3.5.4.2 Japan Ulcerative Colitis Treatment by Medication
9.3.5.5 South Korea Ulcerative Colitis Treatment
9.3.5.5.1 South Korea Ulcerative Colitis Treatment by Type
9.3.5.5.2 South Korea Ulcerative Colitis Treatment by Medication
9.3.5.6 Rest of Asia-Pacific Ulcerative Colitis Treatment
9.3.5.6.1 Rest of Asia-Pacific Ulcerative Colitis Treatment by Type
9.3.5.6.2 Rest of Asia-Pacific Ulcerative Colitis Treatment by Medication
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Ulcerative Colitis Treatment Overview
9.4.2 Middle East and Africa Ulcerative Colitis Treatment Forecasts and Analysis
9.4.3 Middle East and Africa Ulcerative Colitis Treatment Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Ulcerative Colitis Treatment Forecasts and Analysis - By Medication
9.4.5 Middle East and Africa Ulcerative Colitis Treatment Forecasts and Analysis - By Countries
9.4.5.1 South Africa Ulcerative Colitis Treatment
9.4.5.1.1 South Africa Ulcerative Colitis Treatment by Type
9.4.5.1.2 South Africa Ulcerative Colitis Treatment by Medication
9.4.5.2 Saudi Arabia Ulcerative Colitis Treatment
9.4.5.2.1 Saudi Arabia Ulcerative Colitis Treatment by Type
9.4.5.2.2 Saudi Arabia Ulcerative Colitis Treatment by Medication
9.4.5.3 U.A.E Ulcerative Colitis Treatment
9.4.5.3.1 U.A.E Ulcerative Colitis Treatment by Type
9.4.5.3.2 U.A.E Ulcerative Colitis Treatment by Medication
9.4.5.4 Rest of Middle East and Africa Ulcerative Colitis Treatment
9.4.5.4.1 Rest of Middle East and Africa Ulcerative Colitis Treatment by Type
9.4.5.4.2 Rest of Middle East and Africa Ulcerative Colitis Treatment by Medication
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Ulcerative Colitis Treatment Overview
9.5.2 South and Central America Ulcerative Colitis Treatment Forecasts and Analysis
9.5.3 South and Central America Ulcerative Colitis Treatment Forecasts and Analysis - By Type
9.5.4 South and Central America Ulcerative Colitis Treatment Forecasts and Analysis - By Medication
9.5.5 South and Central America Ulcerative Colitis Treatment Forecasts and Analysis - By Countries
9.5.5.1 Brazil Ulcerative Colitis Treatment
9.5.5.1.1 Brazil Ulcerative Colitis Treatment by Type
9.5.5.1.2 Brazil Ulcerative Colitis Treatment by Medication
9.5.5.2 Argentina Ulcerative Colitis Treatment
9.5.5.2.1 Argentina Ulcerative Colitis Treatment by Type
9.5.5.2.2 Argentina Ulcerative Colitis Treatment by Medication
9.5.5.3 Rest of South and Central America Ulcerative Colitis Treatment
9.5.5.3.1 Rest of South and Central America Ulcerative Colitis Treatment by Type
9.5.5.3.2 Rest of South and Central America Ulcerative Colitis Treatment by Medication
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ULCERATIVE COLITIS TREATMENT
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ULCERATIVE COLITIS TREATMENT, KEY COMPANY PROFILES
12.1. PFIZER
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ROCHE
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. JOHNSON AND JOHNSON
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BAYER
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ABBVIE
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SANOFI
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. GSK
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ASTRAZENECA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MSD
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer
2. Novartis
3. Roche
4. Johnson and Johnson
5. Bayer
6. AbbVie
7. Sanofi
8. GSK
9. AstraZeneca
10. MSD
TIPRE00019337
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.